Comparison Bellevue Life Sciences Acquisition (OSRH) with Competitors
Bellevue Life Sciences Acquisition (OSRH) industry is Biotechnology.
Operating Margin
OSRH-758.00%
Industry-2055.25%
Upside+1297.25%
Debt-to-Equity
OSRH0.37%
Industry28.27%
Upside-98.70%
Free Cash Flow Yield
OSRH-37.65%
Industry-1.75%
Upside-35.91%
P/E
OSRH-0.54
Industry-20.52
Upside+1997.51%
P/S
OSRH5.61
Industry10.01
Upside-43.98%
P/B
OSRH0.12
Industry5.15
Upside-97.63%